Danaher earnings were $3.7B for the trailing 12 months ending Mar 27, 2026, with 0% growth year over year. The latest DHR earnings report on Mar 27, 2026 announced Q1 2026 earnings of $1.0B, down 14% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DHR reported annual earnings of $3.6B, with -7.3% growth.
DHR past earnings growth
How has DHR's earnings growth performed historically?
On DHR's earnings call on Invalid Date, Danaher (NYSE: DHR) reported Q1 2026 earnings per share (EPS) of $1.45, up 9.02% year over year. Total DHR earnings for the quarter were $1.03 billion. In the same quarter last year, Danaher's earnings per share (EPS) was $1.33.
As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Mar 27, 2026 was $3.69 billion, a 2.02% decrease year over year.
What was DHR's earnings growth in the past year?
As of Danaher's earnings date in Invalid Date, Danaher's earnings has grown 0% year over year. This is 10.35 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 10.35%. DHR earnings in the past year totalled $3.69 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.